Table 4 Smokescreen addiction genes: source, categories, and counts*
From: Smokescreen: a targeted genotyping array for addiction research
Source | Category | Genes |
|---|---|---|
Gene Ontology | dopamine_receptor_binding | 8 |
Gene Ontology | dopamine_binding | 9 |
Gene Ontology | serotonin_uptake | 4 |
Gene Ontology | serotonin_metabolic_process | 8 |
Gene Ontology | serotonin_transport | 12 |
Gene Ontology | response_to_nicotine | 31 |
Gene Ontology | dopamine_secretion | 15 |
Gene Ontology | dopamine_uptake | 8 |
Gene Ontology | dopamine_receptor_signaling_pathway | 30 |
Gene Ontology | dopamine_transport | 23 |
Gene Ontology | serotonin_secretion | 8 |
Gene Ontology | dopamine_metabolic_process | 26 |
Gene Ontology | regulation_of_dopamine_secretion | 15 |
IPA | cigarette_habituation_susceptibility_syndrome | 6 |
IPA | nicotine | 14 |
IPA | susceptibility_to_drug_addiction | 1 |
IPA | addiction_behavior | 24 |
IPA | tobacco | 27 |
IPA | addiction | 131 |
IPA | withdrawal | 11 |
IPA | smoking | 12 |
IPA | naltrexone | 4 |
IPA | clonidine | 7 |
IPA | nortripyline | 3 |
IPA | varenicline | 3 |
IPA | nicotine | 19 |
IPA | bupropion | 3 |
NIDA Genetics Consortium | The Nicotine System | 20 |
NIDA Genetics Consortium | The Dopamine System | 10 |
NIDA Genetics Consortium | Mouse QTL | 423 |
NIDA Genetics Consortium | The Alcohol System | 32 |
NIDA Genetics Consortium | The Cholinergic System | 9 |
NIDA Genetics Consortium | The Adrenergic System | 16 |
NIDA Genetics Consortium | Tyrosine | 3 |
NIDA Genetics Consortium | Other | 263 |
NIDA Genetics Consortium | The GABA System | 31 |
NIDA Genetics Consortium | Neurotransmitter Transporters | 13 |
NIDA Genetics Consortium | The Nicotine Metabolism System | 11 |
NIDA Genetics Consortium | The Serotonergic System | 20 |
NIDA Genetics Consortium | The Endocannabinoid System | 2 |
NIDA Genetics Consortium | Dopamine Synthesis | 2 |
NIDA Genetics Consortium | The Glutamatergic System | 42 |
NIDA Genetics Consortium | The Opioid System | 12 |
PNAT | Â | 134 |